10.7554/eLife.02523.001 Exchange of extracellular cystine for intracellular glutamate by the
antiporter system x c − is implicated in numerous pathologies. Pharmacological agents that …

Mutation at the R132 residue of isocitrate dehydrogenase 1 (IDH1), frequently found in
gliomas and acute myelogenous leukemia, creates a neoenzyme that produces 2-…

Glutaminase (GLS), which converts glutamine to glutamate, plays a key role in cancer cell
metabolism, growth, and proliferation. GLS is being explored as a cancer therapeutic target, …

We describe here a new strategy for the treatment of stroke, through the inhibition of NAALADase
(N-acetylated-α-linked-acidic dipeptidase), an enzyme responsible for the hydrolysis of …

BACKGROUND: Palonosetron is a 5-HT 3-receptor antagonist (5-HT 3-RA) that has been
shown to be superior to other 5-HT 3-RAs in phase III clinical trials for the prevention of acute, …

6-Diazo-5-oxo-l-norleucine (DON) is a glutamine antagonist that suppresses cancer cell
metabolism but concurrently enhances the metabolic fitness of tumor CD8 + T cells. DON …

Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES) is a potent and selective
allosteric inhibitor of kidney-type glutaminase (GLS) that has served as a molecular probe …

Palonosetron is a 5-HT 3 receptor antagonist that has demonstrated superiority in preventing
both acute and delayed emesis when compared to older first generation 5-HT 3 receptor …

Upon antigen recognition and co-stimulation, T lymphocytes upregulate the metabolic machinery
necessary to proliferate and sustain effector function. This metabolic reprogramming in …

d-Amino acid oxidase (DAAO) catalyzes the oxidation of d-amino acids including d-serine, a
full agonist at the glycine site of the NMDA receptor. A series of benzo[d]isoxazol-3-ol …